MoneyWorks4Me

Glenmark Pharmaceuticals allots 21,800 shares under ESOS

18 Jul 2013 Evaluate

Glenmark Pharmaceuticals has informed that the Operations Committee of the Board of Directors of the Company, at its Meeting held on July 18, 2013 allotted 21,800 shares to the employees of the company on exercise of options granted to them pursuant to ESOS 2003.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..